NCT01785836 - An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris | Biotech Hunter

Timeline

Start Date

March 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Acne Vulgaris

Interventions

DRUG

Dapsone Formulation A

Dapsone Formulation A applied once daily to the face and upper chest, upper back, and shoulders (as per protocol) for 12 weeks.

DRUG

Dapsone Formulation B

Dapsone Formulation B applied once daily to the face and upper chest, upper back, and shoulders (as per protocol) for 12 weeks.

DRUG

Dapsone Formulation C

Dapsone Formulation C applied once daily to the face and upper chest, upper back, and shoulders (as per protocol) for 12 weeks.

DRUG

Dapsone 5% Gel

Dapsone 5% gel (ACZONE®) applied twice daily to the face and upper chest, upper back, and shoulders (as per protocol) for 12 weeks.